Community-associated methicillin-resistant Staphylococcus aureus infections in the athlete

Sports Health

Volumn 1, Issue 5, 2009, Pages 405-410

  Weber, Kathleen ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Methicillin resistant Staphlococcus aureus; Prevention; Treatment

Indexed keywords

EID: 84856140501     PISSN: 19417381     EISSN: 19410921     Source Type: Journal    
DOI: 10.1177/1941738109343653     Document Type: Review

References (35)

1. Bartlett PC, Martin RJ, Cahill BR. Furunculosis in a high school football team. Am J Sports Med., 1982;10:371-374.
2. Binh AD, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureu., clone USA300 in men who have sex with men. Ann Intern Med., 2008;148(4): 249-257.
3. Boyce JM. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect., 2001;48(suppl A): S9-S14.
4. Buescher ES. Community-acquired methicillin-resistant Staphylococcus aureu., in pediatrics. Curr Opin Pediatr., 2005;17;67-70.
5. Centers for Disease Control. Community-acquired methicillin-resistant Staphylococcus aureu., infections: Michigan. MMWR Morb Mortal Wkly Rep., 1981;30:185-187.
6. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA., 1999;282:1123-1125.
7. Centers for Disease Control and Prevention. Community-associated MRSA information for clinicians. http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca_clinicians.html. Accessed July 14, 2009.
8. Centers for Disease Control and Prevention. Environmental management of staph and MRSA in community settings. http://www.cdc.gov/ncidod/dhqp/ ar_mrsa_Enviro_Manage.html. Accessed July 14, 2009.
9. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureu., in correctional facilities: Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep., 2003;52:992-995.
10. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureu., infections among competitive sports participants: Colorado, Indiana, Pennsylvania and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep., 2003;53:793-795.
11. Center for Disease Control and Prevention. Strategies for clinical management of MRSA in the community: March 2006. http://www.cdc.gov/ncidod/dhqp/ pdf/ar/CAMRSA_ExpMtgStrategies.pdf. Accessed July 14, 2009.
12. Chambers HF. The changing epidemiology of Staphylococcus aureus, Emerg Infect Dis., 2001;7(2):178-182.
13. Cohen P, Grossman M. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureu., skin infections. J Am Acad Dermatol., 2004;51:132-135.
14. Cohen P, Kurzrock R. Community acquired methicillin-resistant Staphylococcus aureu., skin infection: an emerging clinical problem. J Am Acad Dermatol., 2004; 50:277-280.
15. Crum NF, Lee RU, Thornton MS, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus, Am J Med., 2006;119:943-951.
16. Daum RS, Ito T, Hiramatsa K, et al. A novel methicillin-resistant Staphylococcus aureu., isolates of diverse genetic backgrounds. J Infect Dis., 2002;186:1344-1347.
17. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA 300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus, Lancet., 2006;367:731-739.
18. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureu., colonization and infection in soldiers. Clin Infect Dis., 2004;39:971-979.
19. Faden H, Ferguson S. Community-acquired methicillin-resistant Staphylococcus aureu., and intra-family spread of pustular disease. Pediatr Infect Dis J., 2001;20:554-555.
20. File TM. Impact of community acquired methicillin-resistant Staphylococcus aureu., in the hospital setting. Cleve Clin J Med, 2007;74(suppl 4):S6-S11.
21. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureu., disease in three communities. N Engl J Med., 2005;352:1436-1444.
22. Graham PL, Lin SX, Larson ELA. US population-based survey of Staphylococcus aureu., colonization. Ann Intern Med., 2006;144:318-325.
23. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureu., in hospitalized adults and children without known risk factors. Clin Infect Dis., 1999;29:797-800.
24. Kazakova S, Hageman J, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureu., among professional football players. N Engl J Med., 2005;352:468-475.
25. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicilling-resistant Staphylococcus aureu., USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med., 2006;144:309-317.
26. Lindenmayer J, Schoenfeld S, O'Grady R, Carney J. Methicillin resistant Staphylococcus aureu., in a high school wrestling team and the surrounding community. Arch Intern Med., 1998;158:895-899.
27. Lu D, Holtom P. Community-associated methicillin-resistant Staphylococcus aureus, a new player in sports medicine. Curr Sports Med Rep., 2005;4:265-270.
28. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S aureu., infections among patients in the emergency department. N Engl J Med., 2006;355:666-674.
29. Rice L. Antimicrobial resistance in gram positive bacteria. Am J Med., 2006;119(6)(suppl 1): S11-S19.
30. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus, a meta-analysis of prevalence and risk factors. Clin Infect Dis., 2002;36:131-139.
31. Samad A, Banerjee D, Carbarns N, Ghosh S. Prevalence of methicillinresistant Staphylococcus aureu., colonization in surgical patients on admission to a Welsh hospital. J Hosp Infect., 2002;51(1):43-46.
32. Stacey AR, Endersby KE, Chan PC, Marples RR. An outbreak of methicillin resistant Staphylococcus aureu., infection in a rugby football team. Br J Sports Med., 1998;32:153-154.
33. Vandenesch F, Naimi T, Enright MC, et al. Community acquired methicillin resistant Staphylococcus aureu., carrying the Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis., 2003;9:978-984.
34. Wilcox MH, Hall J, Pike H, et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureu., (MRSA) orthopaedic surgical site infections. J Hosp Infect., 2003;54(3):196-201.
35. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired methicillin resistant Staphylococcus aureus., an emerging threat. Lancet Infec Dis., 2005;5:275-286.